Abstract
The authors recently encountered a lethal case of Down syndrome with transient abnormal myelopoiesis (TAM). Although the peripheral white blood cell count and blast cells had improved without specific treatment, the patient died of severe coagulopathy due to liver fibrosis when he was 5 years old. The prognosis of TAM with liver fibrosis was poor. The patient had high levels of N-terminal peptide of III procollagen, type IV collagen, and hyaluronic acid. These serum makers are noninvasive indicators of liver fibrosis and may be useful as prognostic indicators of TAM in Down syndrome.
MeSH terms
-
Biomarkers / blood
-
Collagen Type IV / blood
-
Disseminated Intravascular Coagulation
-
Down Syndrome / blood
-
Down Syndrome / complications*
-
Down Syndrome / diagnosis
-
Fatal Outcome
-
Female
-
Fetal Diseases / blood
-
Fetal Diseases / diagnosis
-
Humans
-
Hyaluronic Acid / blood
-
Infant, Newborn
-
Liver Cirrhosis / blood
-
Liver Cirrhosis / diagnosis
-
Liver Cirrhosis / etiology
-
Liver Failure / blood
-
Liver Failure / diagnosis
-
Liver Failure / etiology*
-
Male
-
Myelopoiesis*
-
Peptide Fragments / blood
-
Pregnancy
-
Procollagen / blood
-
Prognosis
Substances
-
Biomarkers
-
Collagen Type IV
-
Peptide Fragments
-
Procollagen
-
procollagen Type III-N-terminal peptide
-
Hyaluronic Acid